Építés alatt – nem éles oldal
Belépés

What researchers published on Hepatitis B (krónikus)

26 372 papers, newest first.

Showing 20 of 765

  • Randomizált vizsgálatThe Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334, A Novel Next-Generation Hepatitis B Capsid Assembly Modulator.Journal of viral hepatitis
  • Vizsgálati eredményEthnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation: a prospective multicentre trial (COIN-B).Nature communications
  • Randomizált vizsgálatA Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B.Journal of viral hepatitis
  • Randomizált vizsgálatSafety, Tolerability and Antiviral Activity of GST-HG131 in Chronic Hepatitis B: A Randomized, Double-Blind Phase IIa Study.Liver international : official journal of the International Association for the Study of the Liver
  • Randomizált vizsgálatImpact of resolved hepatitis B virus infection on clinical outcomes in patients with diffuse large B-cell lymphoma: a supplementary analysis of JCOG0601.International journal of hematology
  • Vizsgálati eredménySequential combination of anti-PD-1 antibody and PEG-IFNα in chronic hepatitis B patients: correlates of HBsAg loss with enhanced T-cell responses.Emerging microbes & infections
  • Randomizált vizsgálatALG-020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug-Induced Liver Injury.Journal of viral hepatitis
  • Randomizált vizsgálatA randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs.Hepatology communications
  • Randomizált vizsgálatBepirovirsen induces innate immune proteins independent of HBV.Hepatology international
  • Vizsgálati eredménySafety and efficacy of libevitug in patients with chronic hepatitis B and D virus coinfection: A single-center, open-label, phase IIa trial in China.Hepatology communications
  • Randomizált vizsgálatRisk of Virological Failure After Switch to a Tenofovir-Sparing Dual Therapy in Virologically Suppressed People With HIV and Past HBV Infection.Journal of medical virology
  • Randomizált vizsgálatB/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.AIDS research and therapy
  • Randomizált vizsgálatOutcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.JHEP reports : innovation in hepatology
  • Randomizált vizsgálat[Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
  • Vizsgálati eredményPeripartum ALT flares predict earlier postpartum HBeAg clearance in highly viremic HBV-infected women: A long-term follow-up study.JHEP reports : innovation in hepatology
  • Randomizált vizsgálatEffect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trial.PloS one
  • Randomizált vizsgálatVRON-0200 alone and in combination with investigational antivirals for participants with chronic hepatitis B virus infection receiving stable nucleos(t)ide therapy: a phase 1b, randomised, open-label, multicentre trial.The Lancet. Microbe
  • Randomizált vizsgálatPhase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.The New England journal of medicine
  • Vizsgálati eredményEfficacy and Safety of Pegylated Interferon as Rescue Therapy for Patients with Chronic Hepatitis B Who Failed to Achieve Functional Cure After Antisense Oligonucleotides or Small Interfering RNA: A Prospective, Multicentre, Open-Label Randomized Controlled Trial (SPHERE) Protocol.Advances in therapy
  • Randomizált vizsgálatSafety, pharmacokinetics and antiviral activity of AHB‑137 in healthy volunteers and chronic hepatitis B patients: a phase 1a/1b study.Hepatology international